Published : Dec-2017
No. of Pages : 131
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Bacterial Vaginosis 30
Sep 06, 2017: Symbiomix Therapeutics Announces Publication of Pivotal Phase 3 Data for Investigational Solosec for the Treatment of Bacterial Vaginosis 30
Clinical Trial Profile Snapshots 31
Appendix 129
Abbreviations 129
Definitions 129
Research Methodology 130
Secondary Research 130
About GlobalData 131
Contact Us 131
Source 131
List of Tables
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2017* 7
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
List of Figures
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 15
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 130
